Chargement en cours...
Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
BACKGROUND: Hyperprolactinaemia is a troublesome side-effect of treatment with antipsychotics. AIMS: This double-blind, placebo-controlled study aimed at examining the effect of adjunctive treatment with 10 mg aripiprazole on prolactin levels and sexual side-effects in patients with schizophrenia sy...
Enregistré dans:
| Publié dans: | BJPsych Open |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Royal College of Psychiatrists
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4998932/ https://ncbi.nlm.nih.gov/pubmed/27703744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/bjpo.bp.115.001248 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|